Cleared Special

K173170 - Epicardia Anywhere

K173170 is an FDA 510(k) clearance for Epicardia Anywhere, manufactured by Medicomp, Inc.. The device is a Class 2 Cardiovascular device with product code DSI cleared through the Special 510(k) pathway after a 103-day FDA review.

K173170 · Medicomp, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2018
Decision
103d
Days
Class 2
Risk

K173170 is an FDA 510(k) clearance for the Epicardia Anywhere. Classified as Detector And Alarm, Arrhythmia (product code DSI), Class II - Special Controls.

Submitted by Medicomp, Inc. (Melbourne, US). The FDA issued a Cleared decision on January 10, 2018 after a review of 103 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medicomp, Inc. devices

FDA 510(k) Submission Details - K173170

510(k) Number K173170 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2017
Decision Date January 10, 2018
Days to Decision 103 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 125d · This submission: 103d
Pathway characteristics
Modification to existing cleared device.

DSI Device Classification - Class 2, Special Controls

Product Code DSI Detector And Alarm, Arrhythmia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Mdi Consultants
Susan D. Goldstein-Falk

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DSI Detector And Alarm, Arrhythmia

All 243
Devices cleared under the same product code (DSI) and FDA review panel - the closest regulatory comparables to K173170.
Liba3 System
K182532 · National Cardiac, Inc. · May 2019
MobileECG 2 BT
K181658 · Memtec Corporation · Mar 2019
Medicalgorithmics Unified Cardiac Rehabilitation System
K173969 · Medicalgorithmics S.A. · Jul 2018
IntelliVue Patient Monitor
K151681 · Philips Medizin Systeme Boeblingen GmbH · Jul 2015
Medtronic Patient Asistant
K150117 · Medtronic, Inc. · May 2015
IntelliVue Patient Monitor
K150310 · Philips Medizin Systeme Boeblingen GmbH · May 2015